Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

2.7K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

16.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantigen mRNA-LNP Vaccination Drives Therapeutic Efficacy in Preclinical Models for Autoimmunity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial.

European journal of neurology·2026
Same author

Client Participation per Round in Federated Learning for Multiple Sclerosis with Real-World Data.

Studies in health technology and informatics·2026
Same author

Good for All, Not Good Enough for One: Reuse Dilemma in Federated Learning.

Studies in health technology and informatics·2026
Same author

Data-driven hypothesis discovery from disease trajectories in multiple sclerosis.

Frontiers in immunology·2026
Same author

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

CNS drugs·2026
Same journal

Immunogenicity and protective potential of a mucosal protein-only vaccine candidate for tuberculosis.

Frontiers in immunology·2026
Same journal

The role of mitochondrial proteases in inflammation and immunity.

Frontiers in immunology·2026
Same journal

Long term survival in three pancreatic cancer patients following Whipple's procedure and allogeneic hematopoietic cell transplantation.

Frontiers in immunology·2026
Same journal

Innate immune circuits in acute lung injury: macrophage plasticity, ILC crosstalk, and tissue repair failure.

Frontiers in immunology·2026
Same journal

Next-generation CAR-T engineering for colorectal cancer: integrating targets, tumor microenvironment barriers, and emerging strategies.

Frontiers in immunology·2026
Same journal

Comparative assessment of tissue cross-reactivity and pharmacokinetic half-life of malaria monoclonal antibodies.

Frontiers in immunology·2026
See all related articles

Related Experiment Video

Updated: Feb 21, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

7.6K

Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression.

Liesbet M Peeters1, Marjan Vanheusden1, Veerle Somers1

  • 1School of Life Sciences, Biomedical Research Institute, Hasselt University, Transnationale Universiteit Limburg, Diepenbeek, Belgium.

Frontiers in Immunology
|October 6, 2017
PubMed
Summary
This summary is machine-generated.

Cytotoxic CD4+ T cells (CD4+ CTL) correlate with multiple sclerosis (MS) disease severity and predict long-term outcomes. Identifying these cells may lead to personalized MS treatments and improved prognosis.

Keywords:
CD4+CD28null T cellsmultimodal evoked potentialsmultiple sclerosispersonalized medicineprognosisprognostic risk factor

More Related Videos

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

7.8K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

Related Experiment Videos

Last Updated: Feb 21, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

7.6K
Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

7.8K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

Area of Science:

  • Neuroimmunology
  • Immunogenetics

Background:

  • Multiple sclerosis (MS) is a leading cause of neurological disability in young adults, characterized by unpredictable disease progression.
  • Cytotoxic CD4+ T cells (CD4+ CTL), identified as CD4+CD28null T cells, have been implicated in tissue damage and inflammation in MS animal models.

Purpose of the Study:

  • To investigate the correlation between CD4+ CTL presence and clinical outcomes in MS patients.
  • To evaluate the prognostic value of CD4+CD28null T cells in predicting MS disease progression.

Main Methods:

  • Blood samples from 176 relapsing-remitting MS patients were analyzed for the percentage of CD4+CD28null T cells at baseline.
  • Multimodal evoked potentials (EP) and Kurtzke expanded disability status scale (EDSS) were used as outcome measures at baseline, 3 years, and 5 years.

Main Results:

  • A significant association was found between baseline CD4+CD28null T cell percentage and baseline EP, indicating a link to disease severity (P=0.003, R²=0.28).
  • The baseline CD4+CD28null T cell percentage demonstrated prognostic value, correlating with EP at 3 years (P=0.005, R²=0.29) and with EP and EDSS at 5 years (P=0.008, R²=0.42; P=0.003, R²=0.27).

Conclusions:

  • This study establishes the first direct link between CD4+ CTL and MS disease severity and prognosis.
  • Future research should focus on therapeutic strategies targeting CD4+ CTL formation and incorporating immunophenotyping into predictive models for personalized MS medicine.